IMMORTAL: Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer

Phase II Randomized Trial of Atezolizumab Versus Atezolizumab and Radiation Therapy for Platinum Ineligible/Refractory Metastatic Urothelial Cancer (ART)

• Condition:Metastatic Urothelial Carcinoma, Platinum-Resistant Urothelial Carcinoma, Stage IV Bladder Cancer AJCC v8
• Study ID: NCT04936230